Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mala

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cognitive Neurodynamics|July 31, 2023
Facial expression recognition on partially occluded faces using component based ensemble stacked CNNSivaiah Bellamkonda, N P Gopalan, C Mala, et al.
British Journal of Cancer|February 16, 2013
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancerV Heinemann, M P Ebert, R P Laubender, et al.
FEBS Letters|September 14, 1992
The primitive metazoan Hydra expresses antistasin, a serine protease inhibitor of vertebrate blood coagulation: cDNA cloning, cellular localisation and developmental regulationT W Holstein, C Mala, E Kurz, et al.
Journal of Cell Science|May 15, 1998
Spinalin, a new glycine- and histidine-rich protein in spines of Hydra nematocystsA W Koch, T W Holstein, C Mala, et al.
Folia Biologica|June 5, 2003
A prospective open-label single-arm phase II study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patientsZ Varga, P de Mulder, W Kruit, et al.
The Journal of Urology|January 13, 2006
A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinomaI Bleumer, E Oosterwijk, J C Oosterwijk-Wakka, et al.
British Journal of Cancer|March 5, 2004
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patientsI Bleumer, A Knuth, E Oosterwijk, et al.
NPJ Parkinson'S Disease|June 25, 2024
Analysis of striatal connectivity corresponding to striosomes and matrix in de novo Parkinson's disease and isolated REM behavior disorderS Marecek, T Krajca, R Krupicka, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cognitive Neurodynamics|July 31, 2023
Facial expression recognition on partially occluded faces using component based ensemble stacked CNNSivaiah Bellamkonda, N P Gopalan, C Mala, et al.
British Journal of Cancer|February 16, 2013
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancerV Heinemann, M P Ebert, R P Laubender, et al.
FEBS Letters|September 14, 1992
The primitive metazoan Hydra expresses antistasin, a serine protease inhibitor of vertebrate blood coagulation: cDNA cloning, cellular localisation and developmental regulationT W Holstein, C Mala, E Kurz, et al.
Journal of Cell Science|May 15, 1998
Spinalin, a new glycine- and histidine-rich protein in spines of Hydra nematocystsA W Koch, T W Holstein, C Mala, et al.
Folia Biologica|June 5, 2003
A prospective open-label single-arm phase II study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patientsZ Varga, P de Mulder, W Kruit, et al.
The Journal of Urology|January 13, 2006
A clinical trial with chimeric monoclonal antibody WX-G250 and low dose interleukin-2 pulsing scheme for advanced renal cell carcinomaI Bleumer, E Oosterwijk, J C Oosterwijk-Wakka, et al.
British Journal of Cancer|March 5, 2004
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patientsI Bleumer, A Knuth, E Oosterwijk, et al.
NPJ Parkinson'S Disease|June 25, 2024
Analysis of striatal connectivity corresponding to striosomes and matrix in de novo Parkinson's disease and isolated REM behavior disorderS Marecek, T Krajca, R Krupicka, et al.
Pageof 1